홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GLUE
#2226
Monte Rosa Therapeutics, Inc. Common Stock
17.500
0
USD
-0.28%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-0.28%
월간 변동
+5.87%
6달 변화
+54.87%
년간 변동율
+54.87%
이전 종가
17.550
0
Open
17.500
0
Bid
Ask
Low
17.500
0
High
17.500
0
양
99
마켓
주식
헬스케어
GLUE
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
46.63 M
49.36 M
50.15 M
61.51 M
80.02 M
—
Valuation ratios
Enterprise value
606.12 M
329.1 M
158.28 M
202.62 M
1.12 B
1.81 B
Price to earnings ratio
—
-3.38
-2.17
-7.08
-34.09
36.44
Price to sales ratio
—
646.88
-576.57
6.78
10.53
18.09
Price to cash flow ratio
—
-3.97
-6.7
12.21
-57.13
-36.27
Price to book ratio
—
1.35
1.64
2.3
5.59
6.94
EBITDA 비율에 대한 기업 가치
-8.55
-3.14
-1.17
-2.78
-25.94
18.87
Profitability ratios
Return on assets %
-0.2
-0.32
-0.45
-0.17
-0.09
-0.08
Return on equity %
-0.21
-0.4
-0.76
-0.33
-0.17
-0.18
Return on invested capital %
-843.49
-259.65
-266.73
-192.35
-149.4
-302.96
Gross margin %
100
100
100
100
100
400
Operating margin %
40.72 K
-19.79 K
28.16 K
-107.26
-43.83
-2 061.14
EBITDA margin %
39.63 K
-18.45 K
26.54 K
-96.52
-35.05
-1 859.83
Net margin %
41.32 K
-19.1 K
26.59 K
-96.14
-31.23
-1 868.84
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
20.96
10.79
5.07
2.4
6.12
25.43
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
0
-0
0.2
0.28
0.3
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.96
-0.85
0.57
-0.27
-0.27
EBIT per share
—
-2.37
-2.8
-1.1
-0.65
-0.66
EBITDA per share
—
-2.22
-2.63
-0.99
-0.52
-0.5
Total debt per share
—
—
—
—
—
—
Cash per share
—
1.16
2.49
3.03
4.54
13.77
Net current asset value per share
—
5.84
4.6
5.11
4.73
17.26
Tangible book value per share
—
5.75
3.49
3.02
2.81
12.37
Working capital per share
—
5.3
3.69
2.98
3.96
14.52
Book value per share
—
5.75
3.49
3.02
2.81
12.37
뉴스
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates
Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
몬테 로사 테라퓨틱스, 매출 감소 속 실적 발표 예정
Monte Rosa Therapeutics earnings on deck amid revenue decline
Dunn Edmund, principal accounting officer, sells Monte Rosa (GLUE) shares for $2496
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Monte Rosa 주가, 전립선암 임상 시험 결과에 상승
Monte Rosa shares rise on prostate cancer trial results
몬테 로사, 전립선암 치료제 긍정적 임상 데이터 발표
Monte Rosa reports positive trial data for prostate cancer drug
NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates